Mosepele Mosepele, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Botswana | 36 | 2024 | 1034 | 1.990 |
Why?
|
HIV Infections | 42 | 2024 | 16764 | 1.880 |
Why?
|
Meningitis, Cryptococcal | 9 | 2024 | 64 | 1.640 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 293 | 0.680 |
Why?
|
Benzoxazines | 5 | 2019 | 306 | 0.640 |
Why?
|
Anti-HIV Agents | 10 | 2022 | 4320 | 0.590 |
Why?
|
Amphotericin B | 4 | 2022 | 137 | 0.590 |
Why?
|
Cephalosporins | 3 | 2023 | 204 | 0.480 |
Why?
|
Antifungal Agents | 5 | 2023 | 722 | 0.470 |
Why?
|
HIV | 4 | 2023 | 1607 | 0.460 |
Why?
|
Developing Countries | 2 | 2022 | 2779 | 0.420 |
Why?
|
Bartonella Infections | 1 | 2011 | 22 | 0.420 |
Why?
|
Cell Adhesion Molecules | 1 | 2018 | 1599 | 0.410 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2864 | 0.390 |
Why?
|
Cryptococcus neoformans | 2 | 2024 | 119 | 0.380 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 879 | 0.380 |
Why?
|
Antigens, CD | 2 | 2018 | 4024 | 0.360 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1890 | 0.340 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2018 | 2241 | 0.340 |
Why?
|
Flucytosine | 3 | 2023 | 33 | 0.310 |
Why?
|
Africa South of the Sahara | 6 | 2022 | 727 | 0.300 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15070 | 0.300 |
Why?
|
Fluconazole | 3 | 2023 | 145 | 0.300 |
Why?
|
Anti-Retroviral Agents | 3 | 2021 | 1734 | 0.270 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4454 | 0.270 |
Why?
|
CD4 Lymphocyte Count | 5 | 2020 | 2602 | 0.260 |
Why?
|
Viral Load | 5 | 2022 | 3299 | 0.250 |
Why?
|
Pharmacology | 1 | 2004 | 103 | 0.250 |
Why?
|
Atherosclerosis | 2 | 2017 | 3401 | 0.240 |
Why?
|
Gammaproteobacteria | 1 | 2023 | 28 | 0.240 |
Why?
|
Wolves | 1 | 2023 | 9 | 0.230 |
Why?
|
Hypertension | 1 | 2023 | 8431 | 0.230 |
Why?
|
Cryptococcosis | 1 | 2024 | 101 | 0.230 |
Why?
|
Dog Diseases | 1 | 2023 | 136 | 0.210 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 24714 | 0.210 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2022 | 664 | 0.200 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2020 | 1896 | 0.190 |
Why?
|
Problem-Based Learning | 1 | 2004 | 359 | 0.190 |
Why?
|
Enterobacteriaceae Infections | 1 | 2022 | 181 | 0.190 |
Why?
|
E-Selectin | 2 | 2023 | 577 | 0.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2023 | 705 | 0.180 |
Why?
|
Humans | 56 | 2024 | 739398 | 0.180 |
Why?
|
Health Occupations | 1 | 2020 | 221 | 0.170 |
Why?
|
Alkynes | 5 | 2019 | 310 | 0.170 |
Why?
|
Prevalence | 5 | 2023 | 15153 | 0.170 |
Why?
|
Adult | 27 | 2024 | 213394 | 0.160 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 2019 | 624 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 169 | 0.160 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2018 | 53 | 0.160 |
Why?
|
Male | 30 | 2024 | 349022 | 0.160 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2023 | 1153 | 0.160 |
Why?
|
HIV-1 | 4 | 2022 | 6931 | 0.160 |
Why?
|
HIV Seropositivity | 2 | 2022 | 966 | 0.160 |
Why?
|
Cyclopropanes | 5 | 2019 | 421 | 0.160 |
Why?
|
Immune Evasion | 1 | 2022 | 358 | 0.160 |
Why?
|
Pregnancy Outcome | 3 | 2023 | 2789 | 0.150 |
Why?
|
Female | 32 | 2024 | 378853 | 0.140 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2018 | 217 | 0.140 |
Why?
|
Tuberculosis | 2 | 2023 | 1892 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 571 | 0.140 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2018 | 419 | 0.130 |
Why?
|
Education, Medical, Undergraduate | 1 | 2004 | 999 | 0.130 |
Why?
|
Risk Factors | 7 | 2024 | 71974 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 721 | 0.130 |
Why?
|
Stillbirth | 3 | 2023 | 346 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2023 | 1152 | 0.120 |
Why?
|
Drug Costs | 2 | 2019 | 1115 | 0.120 |
Why?
|
Monobactams | 2 | 2023 | 13 | 0.120 |
Why?
|
Case-Control Studies | 5 | 2018 | 21694 | 0.120 |
Why?
|
Sexual Partners | 1 | 2018 | 727 | 0.120 |
Why?
|
Middle Aged | 19 | 2024 | 212863 | 0.120 |
Why?
|
Premature Birth | 2 | 2022 | 1702 | 0.110 |
Why?
|
Comorbidity | 4 | 2021 | 10362 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 629 | 0.110 |
Why?
|
Self Report | 1 | 2024 | 3524 | 0.110 |
Why?
|
Social Class | 1 | 2021 | 1974 | 0.110 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2184 | 0.110 |
Why?
|
Bartonella quintana | 1 | 2011 | 3 | 0.110 |
Why?
|
Trench Fever | 1 | 2011 | 2 | 0.110 |
Why?
|
Malawi | 2 | 2024 | 282 | 0.110 |
Why?
|
American Heart Association | 1 | 2017 | 1050 | 0.110 |
Why?
|
Bartonella | 1 | 2011 | 12 | 0.110 |
Why?
|
Genotype | 5 | 2018 | 12951 | 0.100 |
Why?
|
Bartonella henselae | 1 | 2011 | 16 | 0.100 |
Why?
|
Cat-Scratch Disease | 1 | 2011 | 23 | 0.100 |
Why?
|
Pilot Projects | 5 | 2017 | 8275 | 0.100 |
Why?
|
Social Support | 1 | 2021 | 2112 | 0.100 |
Why?
|
Curriculum | 2 | 2020 | 3575 | 0.100 |
Why?
|
Patients | 1 | 2018 | 890 | 0.100 |
Why?
|
Program Development | 1 | 2017 | 1313 | 0.100 |
Why?
|
Young Adult | 11 | 2023 | 56255 | 0.100 |
Why?
|
Attitude to Health | 1 | 2020 | 2047 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2028 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2022 | 1904 | 0.100 |
Why?
|
Central Nervous System | 1 | 2018 | 1362 | 0.090 |
Why?
|
Medication Adherence | 2 | 2020 | 2047 | 0.090 |
Why?
|
Caregivers | 1 | 2021 | 2067 | 0.090 |
Why?
|
Drug Resistance, Microbial | 2 | 2023 | 860 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2782 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2018 | 2552 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2867 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3194 | 0.080 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2008 | 114 | 0.080 |
Why?
|
Mental Disorders | 2 | 2022 | 6570 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7136 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5462 | 0.080 |
Why?
|
Blood Pressure | 1 | 2023 | 8554 | 0.080 |
Why?
|
Monocytes | 1 | 2017 | 2583 | 0.080 |
Why?
|
Drug Administration Schedule | 3 | 2022 | 4935 | 0.080 |
Why?
|
South Africa | 2 | 2023 | 1743 | 0.080 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 257 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2023 | 6478 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2011 | 845 | 0.070 |
Why?
|
Social Stigma | 2 | 2023 | 695 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2348 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2216 | 0.070 |
Why?
|
Cognition Disorders | 2 | 2011 | 4026 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2044 | 0.070 |
Why?
|
Outpatients | 2 | 2024 | 1469 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7897 | 0.060 |
Why?
|
Phylogeny | 2 | 2023 | 2789 | 0.060 |
Why?
|
Communicable Disease Control | 2 | 2022 | 853 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5265 | 0.060 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2024 | 13 | 0.060 |
Why?
|
Agar | 1 | 2023 | 56 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2016 | 3945 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2020 | 62693 | 0.060 |
Why?
|
Hydrolases | 1 | 2023 | 140 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9133 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1327 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11668 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2016 | 5305 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4671 | 0.050 |
Why?
|
Adolescent | 4 | 2023 | 85405 | 0.050 |
Why?
|
Time Factors | 3 | 2018 | 40050 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15500 | 0.050 |
Why?
|
Depression | 2 | 2012 | 7689 | 0.050 |
Why?
|
Carbapenems | 1 | 2022 | 114 | 0.050 |
Why?
|
Australia | 1 | 2004 | 1162 | 0.050 |
Why?
|
Treatment Failure | 2 | 2017 | 2614 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5128 | 0.050 |
Why?
|
Statistical Distributions | 1 | 2020 | 64 | 0.050 |
Why?
|
Maternal Mortality | 1 | 2022 | 312 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9898 | 0.040 |
Why?
|
Standard of Care | 1 | 2023 | 563 | 0.040 |
Why?
|
Universities | 1 | 2004 | 946 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3916 | 0.040 |
Why?
|
Vitamin D | 1 | 2012 | 3197 | 0.040 |
Why?
|
Personnel Loyalty | 1 | 2017 | 10 | 0.040 |
Why?
|
Authorship | 1 | 2021 | 268 | 0.040 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 438 | 0.040 |
Why?
|
Dogs | 1 | 2023 | 3915 | 0.040 |
Why?
|
Prospective Studies | 5 | 2023 | 53037 | 0.040 |
Why?
|
Drug Resistance, Viral | 1 | 2022 | 829 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 13880 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5761 | 0.040 |
Why?
|
Faculty | 1 | 2020 | 376 | 0.040 |
Why?
|
Health Personnel | 2 | 2020 | 3203 | 0.040 |
Why?
|
Oxazines | 1 | 2018 | 302 | 0.040 |
Why?
|
Hospitalization | 1 | 2016 | 10208 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2022 | 1591 | 0.040 |
Why?
|
Chest Pain | 1 | 2024 | 1112 | 0.040 |
Why?
|
Teaching | 1 | 2004 | 1166 | 0.040 |
Why?
|
Alleles | 2 | 2018 | 6942 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2023 | 20676 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1308 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29002 | 0.030 |
Why?
|
Poverty | 2 | 2022 | 2626 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2024 | 1239 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10455 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 40389 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23294 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 2656 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2062 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2020 | 1008 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2024 | 6174 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5272 | 0.030 |
Why?
|
Administration, Oral | 1 | 2022 | 3909 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2024 | 2040 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1583 | 0.030 |
Why?
|
Pyridones | 1 | 2018 | 707 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1682 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2106 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 10793 | 0.030 |
Why?
|
Life Style | 1 | 2024 | 3817 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1957 | 0.030 |
Why?
|
Activities of Daily Living | 2 | 2012 | 2410 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5460 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4220 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2478 | 0.020 |
Why?
|
Schools, Medical | 1 | 2017 | 878 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2012 | 6028 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18349 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1526 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 845 | 0.020 |
Why?
|
AIDS Dementia Complex | 1 | 2010 | 152 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2484 | 0.020 |
Why?
|
United States | 1 | 2017 | 69573 | 0.020 |
Why?
|
RNA, Viral | 1 | 2017 | 2907 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1557 | 0.020 |
Why?
|
Piperazines | 1 | 2018 | 2480 | 0.020 |
Why?
|
Behavior | 1 | 2011 | 561 | 0.020 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 6963 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 780 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10945 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2624 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7128 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9846 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9684 | 0.020 |
Why?
|
Child | 2 | 2023 | 77033 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10247 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12237 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 38942 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2016 | 3620 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2016 | 5076 | 0.010 |
Why?
|
Urban Population | 1 | 2012 | 2014 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8274 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13402 | 0.010 |
Why?
|
Cognition | 2 | 2011 | 6686 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6295 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25470 | 0.010 |
Why?
|
Aged | 3 | 2022 | 162698 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10398 | 0.010 |
Why?
|
Haplotypes | 1 | 2008 | 2782 | 0.010 |
Why?
|
Suicide | 1 | 2012 | 1469 | 0.010 |
Why?
|
Infant | 1 | 2023 | 34923 | 0.010 |
Why?
|
Memory | 1 | 2010 | 2161 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7726 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 57650 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29658 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20913 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168368 | 0.010 |
Why?
|